Stefan Zajic

6PUBLICATIONS
34CO-AUTHORS
Commercial lawMolecular targetsGene and molecular therapyPharmacogenomicsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 01, 2025
Safety and Tolerability of Lete-cel in NSCLC-Reply.

Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann

|Jan 21, 2025
Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma.

Sandra P D'Angelo, Mihaela Druta, Brian A Van Tine

|Nov 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer.

Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann

|Jul 11, 2020
A phase 1 pooled PK/PD analysis of bone resorption biomarkers for odanacatib, a Cathepsin K inhibitor.

Stefan Zajic, S Aubrey Stoch, Jacqueline B McCrea

Pageof 1